Recent therapeutics in hepatocellular carcinoma

Area of Science:

• Hepatology
• Oncology
• Digestive System Malignancies

Background:

• Hepatocellular carcinoma (HCC) is a prevalent and aggressive liver cancer originating from hepatocytes.
• Early-stage HCC often lacks distinct symptoms, leading to delayed diagnosis and advanced disease at presentation.
• The advanced stage of HCC frequently involves local invasion or distant metastasis, complicating treatment and resulting in poor prognoses.

Purpose of the Study:

• To highlight the clinical importance of effective Hepatocellular carcinoma (HCC) treatment strategies.
• To review recent advancements in managing advanced Hepatocellular carcinoma (HCC).
• To discuss the role of comprehensive, surgery-based treatment modalities in modern HCC therapy.

Main Methods:

• Review of current medical literature on Hepatocellular carcinoma (HCC) treatment.
• Analysis of recent technological advancements impacting HCC management.
• Focus on the integration of surgical approaches within comprehensive HCC treatment plans.

Main Results:

• Hepatocellular carcinoma (HCC) diagnosis commonly occurs at advanced stages, limiting curative options.
• Supportive and symptomatic treatments are often the primary approach for advanced HCC.
• Recent technological progress has enabled comprehensive treatment strategies, increasingly incorporating surgery.

Conclusions:

• Effective treatment of Hepatocellular carcinoma (HCC) remains a critical clinical challenge.
• The prognosis for Hepatocellular carcinoma (HCC) patients is generally poor due to late diagnosis.
• Comprehensive treatment, particularly incorporating surgical interventions, represents a significant advancement in managing Hepatocellular carcinoma (HCC).